alexa Assessment The Effect Of Metformin And Pioglitazone On Oxidative Phenomenon In Type 2 Diabetes Patients
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

5th World Congress on Diabetes & Metabolism
November 03-05, 2014 Embassy Suites Las Vegas, USA

Hossein Mirmiranpour
Accepted Abstracts: J Diabetes Metab
DOI: 10.4172/2155-6156.S1.028
Introduction: Imbalance between production and destruction of reactive molecules leads to oxidative stress (OS). OS can cause impaired glucose metabolism which leads to diabetes mellitus and its complications such as retinopathy, nephropathy and cardiovascular diseases. OS is also believed to become excessive by production of high amounts of OH free radicals resulting from hyperglycemia on the one hand and reduction of activity of anti oxidant enzymes on the other hand. New efforts have focused on inhibition or reduction of free radicals generation, as a pathway, to diminish OS level in the body. One of these efforts is using metformin with a moderately role of OS and pioglitazone with an antioxidative-antiinflammatory role in type 2 diabetes. Methods: Metformin and pioglitazone were daily prescribed to, respectively, 50 and 30 patients with type 2 diabetes. 49 recent patients didn?t receive any medication but only provided with recommendations for lifestyle modification. They were suggested about exercise and dietary activity. At first time and after three months, advanced glycation end products(AGEs), advanced oxidation protein products(AOPP), paraoxonase(PON), lecithin-cholesterol asyltransferase(LCAT) and lipoprotein lipase(LPL) of serum and also ferritin reducing ability of plasma(FRAP) were measured. Results: Both of metformin and pioglitazone reduced the serum quantity of AGEs(p = 0.140) and AOPP(p = 0.688) and also, increased the serum quantity of PON (p = 0.273). Measure of FRAP (p = 0.012) was increased by metformin. Pioglitazone moderated OS and neared the serum levels of LCAT (0.037) and LPL (P = 0.001) to normal values better than metformin. Conclusion: The rate of OS and antioxidant capacity parameters neared to natural level, after three months drug therapy including metformin and pioglitazone.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version